Contribution: Industrial Research Assistance Program – Contributions to Firms
SERAGENE THERAPEUTICS INC.
$33,505.00
SG-001 – Preliminary pharmacokinetic study of siRNA therapeutic
FY 2025-26 · 2025-08-20
Summary
The project will support a pilot study for the lead asset - an siRNA for treatment of a bleeding disorder.
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Recipient
Location
Vancouver|Vancouver, British Columbia, Canada
Recipient Type
For-profit organization
Business Number
713788008
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Amendments
Each version of the agreement as published, oldest first, with its total as of that version. The amount above is the latest.
| Amendment | Date | Fiscal Year | Total |
|---|---|---|---|
| 0 | 2025-08-20 | 2025-26 | $18,990.00 |
| 1 | 2025-08-20 | 2025-26 | $33,505.00 |
As published
Additional Information
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 50 days. The total amended value is 14,515 dollars.
Additional Information (French)
Cet accord a été modifié 1 fois La date de fin du présent accord a été changé de 50 jours. La valeur totale des modifications est de 14 515 dollars.
Agreement End Date
2026-03-31
Agreement Number
1034414
Agreement Start Date
2025-08-20
Agreement Title
SG-001 – Preliminary pharmacokinetic study of siRNA therapeutic
Agreement Title (French)
SG-001 - Étude pharmacocinétique préliminaire d’un siRNA thérapeutique
Agreement Type
Contribution
Agreement Value
$33,505.00
Amendment Date
2025-11-17
Amendment Number
1
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
The project will support a pilot study for the lead asset - an siRNA for treatment of a bleeding disorder.
Description (French)
Le projet soutiendra une étude pilote pour l’actif principal - un siRNA pour le traitement d’un trouble de la coagulation.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Vancouver Quadra
Federal Riding (French)
Vancouver Quadra
Federal Riding Number
59039
NAICS Code
541710
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
713788008
Recipient City
Vancouver|Vancouver
Recipient Country
CA
Recipient Legal Name
SERAGENE THERAPEUTICS INC.
Recipient Postal Code
V6T 1Z3
Recipient Province or Territory
BC
Recipient Type
F
Reference Number
172-2025-2026-Q2-1034414
